MedKoo Cat#: 414571 | Name: Omoconazole nitrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Omoconazole is an imidazole-class antifungal agent primarily used topically to treat superficial mycoses. Its bioactivity stems from inhibition of ergosterol biosynthesis by targeting the fungal cytochrome P450 enzyme lanosterol 14α-demethylase, leading to disruption of cell membrane integrity. In vitro studies demonstrate that omoconazole exhibits potent activity against dermatophytes (Trichophyton spp., Microsporum spp.), yeasts (Candida albicans, Candida tropicalis), and some gram-positive bacteria. Minimum inhibitory concentrations (MICs) for dermatophytes generally range from 0.01 to 1 µg/mL, while for Candida albicans, MIC values typically fall between 0.03 and 0.5 µg/mL

Chemical Structure

Omoconazole nitrate
Omoconazole nitrate
CAS#83621-06-1 (nitrate)

Theoretical Analysis

MedKoo Cat#: 414571

Name: Omoconazole nitrate

CAS#: 83621-06-1 (nitrate)

Chemical Formula: C20H18Cl3N3O5

Exact Mass: 485.0312

Molecular Weight: 486.73

Elemental Analysis: C, 49.35; H, 3.73; Cl, 21.85; N, 8.63; O, 16.44

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Omoconazole nitrate; CM8282; CM-8282; CM 8282;
IUPAC/Chemical Name
1H-Imidazole, 1-(2-(2-(4-chlorophenoxy)ethoxy)-2-(2,4-dichlorophenyl)-1-methylethenyl)-, (Z)-, mononitrate
InChi Key
BNDOPUYTWJQTOE-VSOKSMTPSA-N
InChi Code
InChI=1S/C20H17Cl3N2O2.HNO3/c1-14(25-9-8-24-13-25)20(18-7-4-16(22)12-19(18)23)27-11-10-26-17-5-2-15(21)3-6-17;2-1(3)4/h2-9,12-13H,10-11H2,1H3;(H,2,3,4)/b20-14-;
SMILES Code
C/C(N1C=CN=C1)=C(OCCOC2=CC=C(Cl)C=C2)\C3=CC=C(Cl)C=C3Cl.O[N+]([O-])=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 486.73 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Hashiguchi T, Ryu A, Itoyama T, Uchida K, Yamaguchi H. Study of the effective dose of a topical antifungal agent, omoconazole nitrate, on the basis of percutaneous pharmacokinetics in guinea-pigs and mice. J Pharm Pharmacol. 1997 Aug;49(8):757-61. doi: 10.1111/j.2042-7158.1997.tb06107.x. PMID: 9379351. 2: Itoyama T, Uchida K, Yamaguchi H. Therapeutic effects of omoconazole nitrate on guinea-pigs experimentally infected with Trichophyton mentagrophytes. J Antimicrob Chemother. 1997 Jun;39(6):825-7. doi: 10.1093/jac/39.6.825. PMID: 9222056. 3: Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev. 1988 Apr;1(2):187-217. doi: 10.1128/cmr.1.2.187. PMID: 3069196; PMCID: PMC358042. 4: Itoyama T, Uchida K, Yamaguchi H, Fujita S. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs. J Antimicrob Chemother. 1997 Sep;40(3):441-4. doi: 10.1093/jac/40.3.441. PMID: 9338501. 5: Nishiyama Y, Itoyama T, Yamaguchi H. Ultrastructural alterations of Candida albicans induced by a new imidazole antimycotic omoconazole nitrate. Microbiol Immunol. 1997;41(5):395-402. doi: 10.1111/j.1348-0421.1997.tb01870.x. PMID: 9194038. 6: Babazadeh-Qazijahani M, Badali H, Irannejad H, Afsarian MH, Emami S. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii. Eur J Med Chem. 2014 Apr 9;76:264-73. doi: 10.1016/j.ejmech.2014.02.019. Epub 2014 Feb 11. PMID: 24583607. 7: Uchida K, Itoyama T, Yamaguchi H. [In vitro antifungal activity of omoconazole nitrate, a novel imidazone antimycotic drug, against clinical isolates from patients with cutaneous mycosis]. Jpn J Antibiot. 1996 Aug;49(8):818-23. Japanese. PMID: 9053537. 8: Mosse M, Alric MP, Berceaux M, Fourcine N, Salhi A. Etude comparative de l'activité fongistatique in vitro de l'omoconazole et de six autres imidazolés sur les levures [Comparative study of the fungistatic activity in vitro of omoconazole and 6 other imidazoles against yeasts]. Pathol Biol (Paris). 1986 Jun;34(5 Pt 2):684-7. French. PMID: 3534768. 9: Wang L, Yang W, Wang K, Zhu J, Shen F, Hu Y. Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4887-90. doi: 10.1016/j.bmcl.2012.05.070. Epub 2012 May 24. PMID: 22683344. 10: Zirngibl L, Fischer J, Jahn U, Thiele K. Structure-activity relationships of 2-(1H-imidazol-1-yl)vinyl ethers. Route to the new broad-spectrum antifungal agent omoconazole. Ann N Y Acad Sci. 1988;544:63-73. doi: 10.1111/j.1749-6632.1988.tb40389.x. PMID: 3214095.